Strata Critical Medical (NASDAQ:SRTA) Posts Earnings Results

Strata Critical Medical (NASDAQ:SRTA) announced its quarterly earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%.

Strata Critical Medical Price Performance

Shares of NASDAQ SRTA traded down $0.10 during midday trading on Tuesday, hitting $5.45. The company’s stock had a trading volume of 770,873 shares, compared to its average volume of 958,807. The stock has a market capitalization of $471.93 million, a price-to-earnings ratio of -68.05 and a beta of 2.25. The company’s fifty day moving average price is $5.51. Strata Critical Medical has a 1 year low of $3.67 and a 1 year high of $6.50.

Insiders Place Their Bets

In other Strata Critical Medical news, CAO Amir Cohen sold 4,655 shares of the stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total value of $27,324.85. Following the sale, the chief accounting officer owned 146,608 shares of the company’s stock, valued at $860,588.96. This trade represents a 3.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Melissa M. Tomkiel sold 29,730 shares of Strata Critical Medical stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $5.87, for a total value of $174,515.10. Following the completion of the transaction, the chief executive officer owned 1,892,774 shares of the company’s stock, valued at $11,110,583.38. The trade was a 1.55% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 116,931 shares of company stock worth $687,184 in the last ninety days. 15.50% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $8.00.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.